Compliance for healthtech scaling UK and EU Healhtech Businesses

A clinical lead in Amsterdam wants your product. The budget is signed off, the pilot went well, and then procurement sends a security questionnaire. It asks for your ISO 27001 certificate, your data-transfer arrangements and your EEA representative. The deal does not collapse. It stalls, sitting in someone's inbox until you can answer. Compliance for healthtech scaling UK and EU seldom wins a deal on its own, yet it is routinely what holds one up.

Expansion is when this gets expensive. Each new market you enter adds a standard, sometimes several. A UK enterprise buyer expects ISO 27001. A health system in the Netherlands or Germany brings EU GDPR scope and a representative duty on top of the UK rules you already meet. The UK public-health market adds an assurance stack of its own. Most teams run each market as a separate project and pay the full cost again every time. Build one foundation with market-specific layers on top, and each new market costs less to enter than the last.

What compliance does a healthtech need to scale across the UK and EU?

The universal baseline is ISO 27001 for information security and UK and EU GDPR for data protection, because both are recognised across markets. The UK public-health market then adds the NHS stack: the DSPT, DTAC and, for health IT manufacturers, DCB 0129. Each new market layers its own standards onto the same foundation.

Compliance for healthtech scaling UK and EU: the baseline that travels

Two things do most of the work everywhere you sell. Get them right once and the market-specific frameworks have far less left to ask for.

ISO 27001 is the information-security standard buyers across Europe already recognise. The 2022 version sets out 93 controls in Annex A across four themes, and the certificate is issued by an independent accredited body, held for three years with annual surveillance. UK certification runs through UKAS. Because UKAS sits inside the International Accreditation Forum, a UK-issued certificate is trusted by buyers in Germany, the Netherlands and France without a re-audit. You build the management system once and the proof crosses borders with you.

GDPR is the second pillar, and it works as two regimes in parallel. UK GDPR governs what you do at home. EU GDPR reaches you the moment you sell into the EEA. Under Article 3(2), a business outside the EEA that offers goods or services to people there falls under EU GDPR on top of its UK obligations, so a UK healthtech with European customers answers to both. Article 27 can then require you to appoint an EEA representative, and that duty is independent of adequacy.

Cross-border data flow is the question buyers ask first, and the answer is steady. The European Commission renewed the UK adequacy decisions on 19 December 2025, running under a sunset clause to 27 December 2031. Personal data continues to move from the EEA to the UK without additional transfer safeguards for the life of that decision. The Commission reached that view having taken the Data (Use and Access) Act 2025 into account, an Act that amends UK GDPR rather than replacing it. Where a transfer falls outside adequacy, a Transfer Impact Assessment alongside standard contractual clauses or the UK IDTA is the route to evidence it.

The direction of travel matters too. The EU is building toward a common European Health Data Space, which makes a defensible, reusable data-governance posture worth getting right early rather than retrofitting later.

What entering the UK NHS market adds

Selling into the NHS adds a layer on top of that baseline rather than replacing it. The NHS asks for its own assurance, and your ISO 27001 and GDPR evidence feeds straight into it.

Three standards carry most of the weight. The Data Security and Protection Toolkit, currently DSPT v8, is an annual self-assessment against the National Data Guardian's standards, with the deadline of 30 June 2026 and Category 3 as the usual entry point. The Digital Technology Assessment Criteria, currently DTAC 2.0 published by NHS England in February 2026, assesses software-based digital health technology before procurement across clinical safety, data protection, technical security, interoperability and usability. DCB 0129 is the mandatory clinical-safety standard for health IT manufacturers and requires a named Clinical Safety Officer. Each of these has its own guide, linked at the end of this article.

A medtech building a regulated device may also face medical-device conformity, and that is a separate, parallel regime. EU MDR, the UK medical device regulations administered by the MHRA, and ISO 13485 sit on their own track and are not part of the data, security, information-governance and clinical-safety stack covered here. The 2026 DTAC refresh actually removed elements that overlapped device regulation, which models the clean line: information governance and clinical safety on one side, device conformity on the other.

Map your evidence once, reuse it in every new market

The reason expansion compounds in your favour is that the frameworks share their underlying controls. Access control, risk management, data-protection records, incident handling and supplier due diligence recur across ISO 27001, GDPR, Cyber Essentials and the DSPT. Only the wording changes from one framework to the next; the underlying evidence stays the same.

That changes the order in which you should build. Stand up the universal baseline first, an ISO 27001 management system and a clean GDPR posture, and each market-specific layer then reuses that work rather than starting again. A security review stops being a project each time and becomes an export. The same control evidence carries from your UK enterprise deals into your EU deals and into an NHS submission, so the second market costs less than the first and the third costs less again.

How compliance for healthtech scaling UK and EU gets built

The practical problem is that most teams hold this evidence in scattered documents, then rebuild it framework by framework. So the work that should compound across markets ends up repeated for each one.

This is where a platform earns its place. Naq runs the frameworks a UK and EU healthtech needs, ISO 27001, UK and EU GDPR, NHS DSPT, DTAC and DCB 0129, as one connected system, so a control proven once maps across every framework it supports and the reuse is visible rather than assumed. The judgement-heavy parts have named people behind them: in-house Clinical Safety Officers and virtual Data Protection Officers, with Cyber Essentials certification handled directly as an IASME Certifying Body. The platform's AI assistant is read-only by design and never edits the formal record.

For a company scaling across both markets, the footprint matters. Naq operates as Naq Cyber UK Ltd in London and Naq Cyber B.V. in Amsterdam, a UK and Netherlands presence that mirrors the territory its customers are expanding into. Reuse figures shown in the product are illustrative.

When a buyer in another market sends the questionnaire, you answer from evidence you already hold, and the deal keeps moving.

To see your own frameworks mapped against evidence you already have, book a 15-minute demo and discovery session.

Frequently asked questions

What compliance does a healthtech need to scale across the UK and EU?

Two things travel across every market: ISO 27001 for information security and UK and EU GDPR for data protection. The UK public-health market then layers on the NHS stack, the DSPT, DTAC and, for health IT manufacturers, DCB 0129, all built on the same evidence base.

Is UK-to-EU data transfer still allowed after the Data (Use and Access) Act?

Yes. The European Commission renewed UK adequacy on 19 December 2025, running to 27 December 2031, having taken the Data (Use and Access) Act 2025 into account. Personal data continues to move from the EEA to the UK without additional transfer safeguards for the duration of that decision.

Does a UK healthtech still need to meet EU GDPR when selling into Europe?

Yes. EU GDPR Article 3(2) reaches businesses outside the EEA that offer goods or services to people there, so a UK healthtech with EU customers is subject to EU GDPR on top of UK GDPR. It may also need an EEA representative under Article 27, which adequacy does not remove.

Does Naq handle medical-device regulation like EU MDR or ISO 13485?

No. Device conformity under EU MDR, the UK medical device regulations and ISO 13485 is a separate, parallel regime. Naq covers the data protection, information security, information governance and clinical-safety stack: UK and EU GDPR, ISO 27001, the NHS DSPT, DTAC and DCB 0129.

‍